Cancer Control Research
1R13CA093424-01
Syrjala, Karen L.
BIOBEHAVIORAL AND SUPPORTIVE NEEDS DURING HIGH DOSE TMT
Abstract
DESCRIPTION (provided by applicant):
This R-13 application requests support for an investigator-initiated domestic
scientific meeting to be held at the Fred Hutchinson Cancer Research Center in
Seattle, Washington on September 12-14, 2001. The conference, entitled
"Biobehavioral and Supportive Care Needs During High Dose Treatment," is
cosponsored thus far by the Fred Hutchinson Cancer Research Center and the
Seattle Cancer Care Alliance with the American Cancer Society. The meeting
brings together internationally recognized speakers and a national audience of
cancer researchers and practitioners to convene on a topic that, to our
knowledge, has not yet had such a conference. Need for this scientific forum
is demonstrated by rising rates of survival from transplants in cancer
patients and a dramatic increase in the publishing of biobehavioral research
on cancer patients receiving high dose treatment in the past decade.
Historically, focused scientific exchange about this topic has been held in
Europe, at invitation-only small group workshops. In the proposed format, our
goal is to provide an open forum for the exchange of research results,
methodology, new directions for investigation and methods for meeting clinical
needs of this specialized population of cancer patients. The agenda will meet
the following objectives: 1 ) Review medical treatment options, methods and
new directions for patients with malignancies treated with high dose
chemotherapy and transplant; 2) Examine the status of biobehavioral research
and supportive care needs during acute treatment for high does recipients; 3)
Review medical complications and the status of medical research on recovery
and long-term survivors of high dose treatment; 4) Examine recent
biobehavioral research on recovery and lonq-term survivorship for high dose
recipients; 5) Define active and needed directions for biobehavioral research
on issues faced by high dose treatment recipients; and 6) Define guidelines
for meeting the biobehavioral and supportive care needs of patients and
survivors of high dose treatment. This meeting has the confirmed
participation of nearly all proposed speakers. The meeting will be of
interest to scientists and clinicians working on meeting needs of high dose
treatment recipients, primarily but not solely, transplant patients.
Participants are expected to include: psychologists, hematologic oncologists,
medical oncologists, psychiatrists, nurses, social workers and specialists
providing palliative and supportive care to these patients and survivors.
|